This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignees: Senju Pharmaceutical Co., Ltd., The Doshisha. Active years: 2024.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2024
Title: Mayumi Yamamoto: Innovator in Corneal Endothelial Disease Treatment
Introduction
Mayumi Yamamoto is a prominent inventor based in Osaka, Japan. She has made significant contributions to the field of ophthalmology, particularly in the treatment of corneal endothelial diseases. Her innovative work has led to the development of a unique composition aimed at addressing these medical conditions.
Latest Patents
Yamamoto holds a patent for a composition or method that includes (T)EW-7197 for treating or preventing corneal endothelial diseases. The present disclosure provides a composition specifically designed for treating or preventing symptoms, disorders, or diseases of the corneal endothelium. This invention includes (T)EW-7197, a derivative thereof, a pharmaceutically acceptable salt thereof, or a solvate of any of the foregoing.
Career Highlights
Throughout her career, Mayumi Yamamoto has worked with notable organizations, including Doshisha University and Senju Pharmaceutical Co., Ltd. Her work has been instrumental in advancing research and development in her field.
Collaborations
Yamamoto has collaborated with esteemed colleagues such as Noriko Koizumi and Naoki Okumura. These partnerships have further enriched her research and contributed to her innovative projects.
Conclusion
Mayumi Yamamoto's contributions to the treatment of corneal endothelial diseases highlight her role as a leading inventor in the medical field. Her innovative patent and collaborations reflect her commitment to advancing healthcare solutions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile